trial · primary record
Tezepelumab
Chronic Rhinosinusitis With Nasal Polyps
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 181 |
| Primary completion | 2027-01-13 |
| Primary endpoint | Change from baseline in nasal congestion |
| Registry ID | NCT06706817 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:55:07.748Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06706817
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.